Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?

By applying polymerase chain reaction (PCR) test for Covid-19 to preeclampsia patients who applied to our hospital during the Covid-19 pandemic period, we investigated the frequency of Covid-19 related preeclampsia-like syndrome in this patient group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Female Urogenital Diseases and Pregnancy Complications Hypertension, Pregnancy-Induced Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral Pre-Eclampsia Preeclampsia Pregnancy Complications Pregnancy Related RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Urogenital Diseases Virus Diseases

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Zeynep Kamil Maternity and Childrens Training and Research Hospital

Istanbul, 34660, Turkey (Türkiye)

About this study

The investigators studied the frequency of Covid-19 related preeclampsia-like syndrome by PCR test and lung ultrasound for Covid-19 to preeclampsia patients presenting to the instutution during the Covid-19 pandemic period. The first consecutive 100 preeclampsia patients presented to our hospital during the pandemic will be involved in our study. The primary outcome measure is to detect Covid-19 positivity among the preeclamptic pregnant women..

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

First consecutive 100 pregnant women presenting with preeclamptic symptoms and signs between March 15, 2020 and June 1, 2020.

Exclusion criteria

The pregnancies with known diagnosis of preeclampsia before Covid-19 pandemic
Preeclamptic patient without a Covid-19 PCR test result
Pregnant women who does not want to participate in study or does not want their personal informations to be shared
Pregnant women less than 18 years old and more than 40 years old are excluded

Treatment and study plan

PCR, lung ultrasound

Diagnostic Test

PCR for Covid-19

Primary outcomes

PCR positivity

Time frame: 3 months

To detect Covid-19 PCR test positivity among preeclamptic pregnant women

Sponsors and collaborators

Lead sponsor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Other

Registry information

Official study title

Evaluation of COVID-19 Incidence in Patients With Preeclampsia During Pandemic

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Jun 23, 2020
Registry last updated: Jul 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed